Synergism of CTLA4-IG and anti-CD4 monoclonal antibody treatment in a rat kidney transplant model

Transplant Proc. 1997 Feb-Mar;29(1-2):1307-9. doi: 10.1016/s0041-1345(96)00624-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept
  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD
  • Antigens, Differentiation / analysis
  • Antigens, Differentiation / therapeutic use*
  • CD4 Antigens / immunology*
  • CTLA-4 Antigen
  • Creatinine / blood
  • Cytokines / analysis
  • Drug Synergism
  • Graft Survival*
  • Immunoconjugates*
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / pathology
  • Kidney Transplantation / physiology
  • Rats
  • Rats, Inbred Strains
  • Rats, Inbred WF
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation
  • CD4 Antigens
  • CTLA-4 Antigen
  • Ctla4 protein, rat
  • Cytokines
  • Immunoconjugates
  • Immunosuppressive Agents
  • Abatacept
  • Creatinine